Paper Details

  1. Home
  2. Paper Details

Comparison of albuterol to isoproterenol as a bronchodilator for use in pulmonary function testing.

Author: AdameD, CasaburiR, HongC K

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Albuterol and isoproterenol were equally effective as bronchodilators for pulmonary function testing, with both reaching peak response within 5 minutes.
Paper Details　
Original Abstract of the Article :
We compared the effectiveness of albuterol with isoproterenol as a bronchodilator for use in pulmonary function testing. A total of 180 patients presenting for routine pulmonary function testing were randomly assigned to receive 5 mg of either albuterol or isoproterenol by compressed air nebulizer. ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1378/chest.100.6.1597

データ提供：米国国立医学図書館（NLM）

A Race to the Finish Line: Comparing Albuterol and Isoproterenol as Bronchodilators

Pulmonary function testing is a crucial tool for assessing respiratory health, much like navigating the intricate pathways of the desert's canyons. This study investigates the efficacy of albuterol and isoproterenol, two commonly used bronchodilators, in pulmonary function testing.

The Verdict: Albuterol Takes the Lead

The researchers found no significant difference in the effectiveness of albuterol and isoproterenol in terms of their bronchodilator response. However, considering the known cardiovascular side effects of isoproterenol, the researchers concluded that albuterol is the preferred bronchodilator for use in pulmonary function testing.

Navigating Respiratory Health with Confidence

This research provides valuable insights for healthcare professionals seeking to optimize pulmonary function testing. By choosing albuterol as the bronchodilator of choice, they can ensure accurate and safe assessments of respiratory function.

Dr.Camel's Conclusion

Just as the desert's dunes shift and change, respiratory health can fluctuate. This research reminds us that choosing the right tools for assessment and treatment is crucial to maintaining optimal respiratory function. Albuterol emerges as a reliable and safe option for bronchodilation in pulmonary function testing.

Date :
  1. Date Completed 1992-01-08
  2. Date Revised 2019-05-14
Further Info :

Pubmed ID

1959402

DOI: Digital Object Identifier

10.1378/chest.100.6.1597

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.